BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16523384)

  • 1. High-throughput screening, metabolomics and drug discovery.
    Harrigan GG; Yates LA
    IDrugs; 2006 Mar; 9(3):188-92. PubMed ID: 16523384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery.
    Fischer HP
    Biotechnol Annu Rev; 2005; 11():1-68. PubMed ID: 16216773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating molecular design resources within modern drug discovery research: the Roche experience.
    Stahl M; Guba W; Kansy M
    Drug Discov Today; 2006 Apr; 11(7-8):326-33. PubMed ID: 16580974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 5. Hit discovery and hit-to-lead approaches.
    Keseru GM; Makara GM
    Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micro- and nanofluidic systems for high-throughput biological screening.
    Hong J; Edel JB; deMello AJ
    Drug Discov Today; 2009 Feb; 14(3-4):134-46. PubMed ID: 18983933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caenorhabditis elegans: a versatile platform for drug discovery.
    Artal-Sanz M; de Jong L; Tavernarakis N
    Biotechnol J; 2006 Dec; 1(12):1405-18. PubMed ID: 17109493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-throughput electronic biology: mining information for drug discovery.
    Loging W; Harland L; Williams-Jones B
    Nat Rev Drug Discov; 2007 Mar; 6(3):220-30. PubMed ID: 17330071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategic applications of toxicogenomics in early drug discovery.
    Ryan TP; Stevens JL; Thomas CE
    Curr Opin Pharmacol; 2008 Oct; 8(5):654-60. PubMed ID: 18760379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embracing complexity in drug discovery.
    Gund P; Maliski E; Brown F
    Curr Opin Drug Discov Devel; 2007 May; 10(3):252-3. PubMed ID: 17554850
    [No Abstract]   [Full Text] [Related]  

  • 11. Virtual Discovery Europe--Select Biosciences Conference. Computer-aided drug design and screening.
    Kubinyi H
    IDrugs; 2007 Dec; 10(12):869-73. PubMed ID: 18041683
    [No Abstract]   [Full Text] [Related]  

  • 12. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can cell systems biology rescue drug discovery?
    Butcher EC
    Nat Rev Drug Discov; 2005 Jun; 4(6):461-7. PubMed ID: 15915152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Streamlining lead discovery by aligning in silico and high-throughput screening.
    Davies JW; Glick M; Jenkins JL
    Curr Opin Chem Biol; 2006 Aug; 10(4):343-51. PubMed ID: 16822701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of diversity-based, high-throughput screening on drug discovery: "chance favours the prepared mind".
    Snowden M; Green DV
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):553-8. PubMed ID: 18600571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics.
    Posner BA
    Curr Opin Drug Discov Devel; 2005 Jul; 8(4):487-94. PubMed ID: 16022185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of high throughput screening in the early stage of drug research].
    Keserü GM
    Acta Pharm Hung; 2004; 74(1):5-10. PubMed ID: 15524043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics: available results, current research projects in breast cancer, and future applications.
    Claudino WM; Quattrone A; Biganzoli L; Pestrin M; Bertini I; Di Leo A
    J Clin Oncol; 2007 Jul; 25(19):2840-6. PubMed ID: 17502626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomics and drug discovery.
    Van Osta P; Ver Donck K; Bols L; Geysen J
    Cytometry A; 2006 Mar; 69(3):117-8. PubMed ID: 16496374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.